Cancer Biology Community


The Landry Cancer Biology Consortium was created to realize the full potential of the Harvard-wide network of scientists for future contributions to cancer research and is now officially designated as a graduate consortium in the Graduate School of Arts and Sciences (GSAS) and is placed under the Harvard Integrated Life Sciences (HILS) umbrella.


At Harvard, cancer research is conducted in more than a dozen places, including but not limited to Harvard Medical School, Beth Israel Deaconess Medical Center, the Broad Institute, Boston Children’s Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital. Drawing from these various institutions and a dozen different graduate programs, the Landry Cancer Biology Consortium is truly a consortium — bringing together students and faculty mentors at these institutions to elevate the community as a whole.


The Landry Cancer Biology Consortium continues to foster this network through two interconnected efforts. The first consists of diverse programming that enriches the educational experience of students— courses that highlight the current forefront of cancer research not yet found in textbooks, symposia that bring together the brightest scientific minds, and mentoring events where students interact intimately with faculty, industry leaders, and professionals from other cancer-focused fields. The second crucial effort of the Landry Cancer Biology Consortium is its investment in graduate student researchers through its annual Landry Cancer Biology Research Fellowship award program.

Curricular and extracurricular activities not only teach students about cutting-edge research, but also help hone professional skills and make connections that will enable them to truly become leaders in the field. As a result, the Landry Cancer Biology Consortium creates a community that is both stimulating innovation and paving the way for future discoveries for years to come.

If you want to learn more and connect with us, visit our website and follow us on Twitter @LandryCancerBio.